Therefore, in contrast with CRL1 complex regulating the degradation of many tumor suppressors, such as p21, p27, Iκ-Bα and NF1, CRL2 seems to mainly target oncogenic substrates for degradation [24, 59]. Here, NFKBIA is linked to neoplasm.